Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
13F holders, Q3 2021
Institutional positions in Revolution Medicines, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- −16 vs. Q2 2021
- Shares held
- 72.3M
- +1.94M (+2.8%) vs. Q2 2021
- Total value
- $1.99B
- −$244.2M (−10.9%) vs. Q2 2021
- New holders
- 11
- 38 more added
- Sold out
- 27
- 30 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 693 | $40.1B |
| Q1 2026 | 514 | $19.1B |
| Q4 2025 | 387 | $15.9B |
| Q3 2025 | 323 | $8.96B |
| Q2 2025 | 308 | $7.02B |
| Q1 2025 | 284 | $6.83B |
| Q4 2024 | 281 | $8.45B |
| Q3 2024 | 255 | $7.74B |
| Q2 2024 | 223 | $6.54B |
| Q1 2024 | 210 | $5.18B |
| Q4 2023 | 184 | $4.59B |
| Q3 2023 | 168 | $3.11B |
| Q2 2023 | 139 | $2.99B |
| Q1 2023 | 152 | $2.34B |
| Q4 2022 | 135 | $2.10B |
| Q3 2022 | 142 | $1.74B |
| Q2 2022 | 135 | $1.49B |
| Q1 2022 | 126 | $1.89B |
| Q4 2021 | 117 | $1.85B |
| Q3 2021 | 114 | $1.99B |
| Q2 2021 | 130 | $2.23B |
| Q1 2021 | 128 | $3.05B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 1,565,712 | $43.1M | 0.84% | 00.0% | Unchanged |
| BVF Inc | 2,485,049 | $68.4M | 2.67% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 2,750,000 | $75.7M | 0.41% | +250,000+10.0% | Added |
| Casdin Capital, LLC | 2,800,000 | $77.0M | 1.92% | +495,000+21.5% | Added |
| State Street Corp | 2,809,172 | $77.3M | 0.00% | +460,582+19.6% | Added |
| Cormorant Asset Management, LP | 3,144,700 | $86.5M | 3.52% | −193,466−5.8% | Reduced |
| The Column Group LLC | 3,347,245 | $92.1M | 10.47% | 00.0% | Unchanged |
| Bellevue Group AG | 3,458,805 | $95.2M | 0.97% | +1,604,000+86.5% | Added |
| Boxer Capital, LLC | 3,484,264 | $95.9M | 3.35% | 00.0% | Unchanged |
| Wellington Management Group LLP | 4,537,102 | $124.8M | 0.02% | −1,041,946−18.7% | Reduced |
| BlackRock Inc. | 5,106,038 | $140.5M | 0.00% | +287,908+6.0% | Added |
| TRV GP III, LLC | 5,524,031 | $152.0M | 28.85% | 00.0% | Unchanged |
| Vanguard Group Inc | 6,240,198 | $171.7M | 0.00% | +971,634+18.4% | Added |
| FMR LLC | 7,797,884 | $214.5M | 0.02% | −1,736,375−18.2% | Reduced |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −145,886−100.0% | Sold out |
| Octagon Capital Advisors LP | 0 | $0 | 0.00% | −126,136−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −125,700−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −75,797−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −75,137−100.0% | Sold out |
| Burrage Capital Management LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −35,031−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −22,900−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −22,500−100.0% | Sold out |
| Frontier Capital Management Co LLC | 0 | $0 | 0.00% | −21,853−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −20,701−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −18,099−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −17,492−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −12,387−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −10,089−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −8,462−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −7,733−100.0% | Sold out |
| Fernwood Investment Management, LLC | 0 | $0 | 0.00% | −6,725−100.0% | Sold out |
| Grace Capital | 0 | $0 | 0.00% | −6,555−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −2,581−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −2,010−100.0% | Sold out |
| McCarthy Asset Management, Inc. | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −47−100.0% | Sold out |